Literature DB >> 18946333

T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis.

Carlo Chizzolini1.   

Abstract

PURPOSE OF REVIEW: A better comprehension of the interactions between cells of the adaptive immune system with fibroblasts and endothelial cells is required to understand abnormal extracellular matrix deposition, development of pathologic fibrosis, and vasculopathy. RECENT
FINDINGS: Skin T cells with high IL-4 production potential and peripheral blood T cells preferentially expressing chemokine receptors associated with Th2 functions are found in individuals with active systemic sclerosis. Animal models indicate that Th2 cells and IL-13 can induce muscular hypertrophy in pulmonary arterial vasculature. In bleomycin-induced fibrosis, B cells produce fibrogenic cytokines upon interaction of an endogenous ligand (hyaluronan) with toll-like receptor-4. In the sclerodermatous graft versus host model, the lack of tumor necrosis factor-production by CD4+ T cells is permissive for fibrosis development. Dermal fibrosis and capillary loss typical of systemic sclerosis can be reversible after high-dose immunosuppression and hematopoietic stem cell transplantation.
SUMMARY: Although immunosuppressive strategies to treat patients with systemic sclerosis and allied conditions are largely disappointing, thus indicating a permissive rather than causative role of immunoinflammatory events characteristic of the disease, new findings stress that cells of the adaptive immune system play important roles in assisting fibrogenesis and vascular abnormalities. This may help in identifying efficacious strategies aimed at their control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946333     DOI: 10.1097/BOR.0b013e32830c45ae

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  20 in total

1.  Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Authors:  J Baraut; E I Grigore; F Jean-Louis; S H Khelifa; C Durand; F Verrecchia; D Farge; L Michel
Journal:  Bone Marrow Transplant       Date:  2013-12-23       Impact factor: 5.483

Review 2.  Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.

Authors:  Cristiano Sacchetti; Nunzio Bottini
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

3.  Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis.

Authors:  Yuanchen Zhao; Yang Gao; Tananchai Petnak; Wisit Cheungpasitporn; Charat Thongprayoon; Xing Zhang; Teng Moua
Journal:  Respir Res       Date:  2022-06-21

4.  Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Autoimmun Rev       Date:  2013-05-15       Impact factor: 9.754

5.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

6.  Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.

Authors:  Pravitt Gourh; Sandeep K Agarwal; Ezequiel Martin; Dipal Divecha; Blanca Rueda; Haley Bunting; Shervin Assassi; Gene Paz; Sanjay Shete; Terry McNearney; Hilda Draeger; John D Reveille; T R D J Radstake; Carmen P Simeon; Luis Rodriguez; Esther Vicente; Miguel A Gonzalez-Gay; Maureen D Mayes; Filemon K Tan; Javier Martin; Frank C Arnett
Journal:  J Autoimmun       Date:  2009-09-30       Impact factor: 7.094

Review 7.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

Review 8.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors:  Gabriela Kania; Michal Rudnik; Oliver Distler
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

9.  Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.

Authors:  Marie-Elise Truchetet; Nicolò C Brembilla; Elisa Montanari; Yannick Allanore; Carlo Chizzolini
Journal:  Arthritis Res Ther       Date:  2011-10-13       Impact factor: 5.156

10.  Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2.

Authors:  Donatella Amico; Tatiana Spadoni; Marina Rovinelli; Marta Serafini; Giovanna D'Amico; Nadia Campelli; Silvia Svegliati Baroni; Armando Gabrielli
Journal:  Arthritis Res Ther       Date:  2015-03-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.